Full CoverageTop news
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%
By Annika Kim Constantino
Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds
By Katie Kindelan
Novo splits from Hims over obesity drug compounding controversy
Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup
By Peter Loftus & Robb M. Stewart
All coverage
Novo, Hims & Hers engage in war of words after Wegovy deal falls apart
By Stine Jacobsen & Amina Niasse
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
By Steve Gelsi
Hims Crashes After Novo Unexpectedly Yanks Collaboration Deal
By Allison Gatlin
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices
By Mary Cunningham
Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership
By Josh Nathan-kazis & Mackenzie Tatananni
Hims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices
By Aaron McDade
Novo sends Hims packing
By Bryce Elder
Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs
By Naomi Kresge & Madison Muller
Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff’ Wegovy
By Grace Snelling
Novo abruptly ends obesity drug deal with Hims
By Jonathan Gardner
Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats
By Nathaniel Weixel
Health Insurance Companies Pledge New Efforts To Eliminate Prior Authorization Headaches
By Luke Funk
Novo Nordisk dropping Hims could boost other GLP-1 providers
By Katherine Davis
Hims stock plunged 34%; Here’s why
By Harshita Tyagi
HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
By Robbins Geller Rudman
Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'
By Rishabh Mishra
Hims & Hers stock plummets after Novo Nordisk ends Wegovy direct sales deal
By Anjalee Khemlani
Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs
By Patrick Temple-West & Michael Peel
Hims & Hers on track for biggest drop ever after Novo Nordisk ends partnership
By J. Edward Moreno Del Angel
Novo Nordisk Just Axed Its Deal with Hims & Hers. Should You Buy the Dip in HIMS Stock?
By Wajeeh Khan
Hims & Hers Stock Plunges 30% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices
By Aaron McDade
Hims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices
By Aaron McDade